Amrinone (Lactate)
Overview
Cetrorelix is luteinising hormone releasing hormone antagonist, which inhibits the release of gonadotrophins (luteinising hormone and follicle-stimulating hormone). It is used in the treatment of infertility by assisted reproductive techniques.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Drug Interactions
No data regarding the interactions of Cetrorelix was found.
Back to top
Side Effects
Back to top
Dosage
Amrinone (Lactate)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 5 to 10 mcg per kg of body weight per minute | 7.5 (7.5) | As recommended. | IV | Ths is maintanance dose. the dose should be adjusted according to clinical response. Up to 10 mg (base) per kg of body weight per day, although some patients have been given doses up to 18 mg per kg per day for short durations. |
| 750 mcg per kg of body weight. | 750 (750) | As recommended. | IV | Ths is initial dose and is given undiluted slowly over 2-3 mnutes;may be repeated after 30 minutes if necessary. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Amrinone (Lactate) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Amrinone (Lactate) is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Amrinone (Lactate)
Back to top
Manufacturers of
Amrinone (Lactate)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic